Sotiropoulos JX, Kapadia V, Vento M, Rabi Y, Saugstad OD, Kumar RK, Schmölzer GM, Zhang H, Yuan Y, Lim G, Kusuda S, Arimitsu T, Nguyen TT, Kitsommart R, Yeo KT, Oei JL. Oxygen for the delivery room respiratory support of moderate-to-late preterm infants. An international survey of clinical practice from 21 countries.
Acta Paediatr 2021;
110:3261-3268. [PMID:
34473855 DOI:
10.1111/apa.16091]
[Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Revised: 08/20/2021] [Accepted: 08/31/2021] [Indexed: 12/11/2022]
Abstract
AIM
The aim of this study was to determine clinician opinion regarding oxygen management in moderate-late preterm resuscitation.
METHODS
An anonymous online questionnaire was distributed through email/social messaging platforms to neonatologists in 21 countries (October 2020-March 2021) via REDCap.
RESULTS
Of the 695 respondents, 69% had access to oxygen blenders and 90% had pulse oximeters. Respondents from high-income countries were more likely to have oxygen blenders than those from middle-income countries (72% vs. 66%). Most initiated respiratory support with FiO2 0.21 (43%) or 0.3 (36%) but only 45% titrated FiO2 to target SpO2 . Most (89%) considered heart rate as a more important indicator of response than SpO2 . Almost all (96%) supported the need for well-designed trials to examine oxygenation in moderate-late preterm resuscitation.
CONCLUSION
Most clinicians resuscitated moderate-late preterm infants with lower initial FiO2 but some cannot/will not target SpO2 or titrate FiO2 . Most consider heart rate as a more important indicator of infant response than SpO2 .Large and robust clinical trials examining oxygen use for moderate-late preterm resuscitation, including long-term neurodevelopmental outcomes, are supported amongst clinicians.
Collapse